IP Library Granted Patent US 9,771,622
Granted Patent B2
US 9,771,622 · App. 15/180,790 · Granted Sep 26, 2017

Non-replicative transduction particles and transduction particle-based reporter systems

Inventors: Diego Ariel Rey (Palo Alto, CA); Nikol de Forest (Scotts Valley, CA); Heather Cox (Los Gatos, CA); Soni Shukla (Santa Clara, CA)
Assignee: Geneweave Biosciences, Inc.
C12Q1/6897C12N1/20C12N7/00C12N15/70C12N15/74C12Q1/14C12Q1/18C12Q1/66C12Y113/12007C12N2795/10143C12N2795/10152C12N2795/10343C12N2795/10352G01N2333/31G01N2333/90241
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,771,622
App. No.
15/180,790
Granted
Sep 26, 2017
Kind
B2
Abstract

Methods and systems are provided for packaging reporter nucleic acid molecules into non-replicative transduction particles for use as reporter molecules. The non-replicative transduction particles can be constructed from viruses and use viral transduction and replication systems. The reporter nucleic acid molecules include a reporter gene, such as a reporter molecule or selectable marker, for detecting target genes or cells. Methods and systems are provided for detection of cells and target nucleic acid molecules using the non-replicative transduction particles as reporter molecules.

Claims (27)

1. A method for producing and collecting a plurality of non-replicative transduction particles (NRTPs), comprising:

(a) inducing a lytic phase of the bacterial cell packaging system, wherein said bacterial cell packaging system comprises: a host bacteria cell; a first nucleic acid construct inside the host bacteria cell, comprising of a bacteriophage genome having a first bacteriophage gene that contains a non-functional packaging initiation site sequence, wherein the non-functional packaging initiation site sequence prevents packaging of the bacteriophage genome into the NRTP; and a second nucleic acid construct inside the host bacteria cell and separate from the first nucleic acid construct, comprising of a reporter nucleic acid molecule having a reporter gene and a second bacteriophage gene that contains a functional packaging initiation site sequence for facilitating packaging of a replicon of the reporter nucleic acid molecule into the NRTP, wherein the functional packaging initiation site sequence within the bacteriophage gene on the second nucleic acid construct complements the non-functional packaging initiation site sequence in the bacteriophage genome on the first nucleic acid construct;

(b) allowing the replicon of the reporter nucleic acid molecule to be packaged to produce the NRTPs; and

(c) collecting a lysate comprising the plurality of NRTPs.

2. The method of claim 1 , wherein the lysate is stable at room temperature.

3. The method of claim 1 , wherein the reporter gene is luxAB.

4. The method of claim 1 , wherein the reporter gene is operatively linked to a constitutive promoter.

5. The method of claim 4 , wherein the constitutive promoter is a Staphylococcus aureus ( S. aureus ) clpB promoter.

6. The method of claim 4 , wherein the constitutive promoter is an Enterobacteriaceae β-lactamase gene bla promoter.

7. The method of claim 1 , wherein the reporter nucleic acid molecule is a plasmid comprising at least one origin of replication.

8. The method of claim 7 , wherein the at least one origin of replication is a pT181-derived origin of replication.

9. The method of claim 7 , wherein the at least one origin of replication is a pBBR1-derived origin of replication.

10. The method of claim 1 , wherein the bacteriophage is φ80α.

11. The method of claim 1 , wherein the bacteriophage is P1.

12. A method for detecting a presence or an absence of a bacterial cell in a sample, comprising:

(a) contacting the sample with a lysate comprised of a plurality of non-replicative transduction particles (NRTPs) such that the plurality of NRTPs transduces one or more of the bacterial cells in the sample,

wherein the plurality of NRTPs are produced by (i) inducing a lytic phase of a bacterial cell packaging system, wherein said bacterial cell packaging system comprises: a host bacteria cell; a first nucleic acid construct inside the host bacteria cell, comprising of a bacteriophage genome having a first bacteriophage gene that contains a non-functional packaging initiation site sequence, wherein the non-functional packaging initiation site sequence prevents packaging of the bacteriophage genome into the NRTP; and a second nucleic acid construct inside the host bacteria cell and separate from the first nucleic acid construct, comprising of a reporter nucleic acid molecule having a reporter gene and a second bacteriophage gene that contains a functional packaging initiation site sequence for facilitating packaging of a replicon of the reporter nucleic acid molecule into the NRTP, wherein the functional packaging initiation site sequence within the bacteriophage gene on the second nucleic acid construct complements the non-functional packaging initiation site sequence in the bacteriophage genome on the first nucleic acid construct; (ii) allowing the replicon of the reporter nucleic acid molecule to be packaged to produce the NRTPs;

(b) providing conditions for expression of the reporter gene; and

(c) detecting the presence or absence of a signal produced by the reporter gene, wherein the presence of the signal indicates the presence of the bacteria cell, and wherein the absence of the signal indicates the absence of the bacteria cell.

13. The method of claim 12 , wherein the bacterial cell is Staphylococcus aureus ( S. aureus ).

14. The method of claim 12 , further comprising providing an antimicrobial agent to the sample and detecting for the presence or absence of a signal produced by the reporter gene to determine whether the sample contains a cell that is resistant or susceptible to the antimicrobial agent.

15. The method of claim 1 wherein the second bacteriophage gene is a terminase gene.

16. The method of claim 12 wherein the second bacteriophage gene is a terminase gene.

17. The method of claim 16 wherein the terminase gene is a φ80α small terminase (terS) gene.

18. The method of claim 16 wherein the terminase gene is a P1 pacA terminase gene.

19. The method of claim 15 , wherein the terminase gene is a φ80α small terminase (terS) gene.

20. The method of claim 15 , wherein the terminase gene is a P1 pacA terminase gene.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2021
From: GENEWEAVE BIOSCIENCES, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 056964/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: REY, DIEGO ARIEL; DE FOREST, NIKOL; COX, HEATHER; SHUKLA, SONI
To: GENEWEAVE BIOSCIENCES, INC.
Reel/Frame 055689/0705 →
Continuity (6)
Division 14550335 · Nov 21, 2014
Continuation In Part PCTUS2014026536 · Mar 13, 2014
Provisional Application 61939126 · Feb 12, 2014
Provisional Application 61897040 · Oct 29, 2013
Provisional Application 61779177 · Mar 13, 2013
Related Publication 20160281179A1 · Sep 29, 2016